Man Group
IRMD icon

Man Group’s iRadimed IRMD Stock Holding History

Man Group’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,762
Closed -$250K – 2279
2025
Q1 		$250K Buy
4,762
+990
+26% +$55.6K ﹤0.01% 1978
2024
Q4 		$207K Sell
3,772
-10,006
-73% -$527K ﹤0.01% 1867
2024
Q3 		$693K Buy
13,778
+1,141
+9% +$52.6K ﹤0.01% 1586
2024
Q2 		$555K Buy
12,637
+6,941
+122% +$295K ﹤0.01% 1657
2024
Q1 		$251K Sell
5,696
-19,479
-77% -$861K ﹤0.01% 1969
2023
Q4 		$1.2M Buy
+25,175
New +$1.06M ﹤0.01% 1398
2023
Q3 		– Sell
-20,629
Closed -$959K – 1307
2023
Q2 		$985K Buy
+20,629
New +$930K ﹤0.01% 1389
2023
Q1 		– Sell
-8,012
Closed -$291K – 1657
2022
Q4 		$227K Buy
+8,012
New +$229K ﹤0.01% 1724

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group's IRMD Position: Q2 2025 in Review

Man Group sold out of iRadimed (IRMD) in Q2 2025, closing a stake of 4,762 shares — an estimated $250K sold.

Man Group first reported a position in IRMD in Q4 2022 and held it in 8 quarters. The position peaked at $1.2M in Q4 2023. 162 funds tracked by Wall St. Rank hold IRMD as of Q2 2025.

  • Man Group reported no remaining iRadimed position as of Q2 2025 after selling out during the quarter.
  • Man Group sold 4,762 iRadimed shares in Q2 2025, an estimated $250K.
  • Man Group first reported a position in iRadimed in Q4 2022 and held it in 8 quarters.
  • Man Group's iRadimed position peaked at $1.2M in Q4 2023.
  • 162 funds tracked by Wall St. Rank held iRadimed as of Q2 2025.

Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.